ATE410419T1 - Cannabinoid kristalline derivate und verfahren zur reinigung von cannabinoiden - Google Patents

Cannabinoid kristalline derivate und verfahren zur reinigung von cannabinoiden

Info

Publication number
ATE410419T1
ATE410419T1 AT03781830T AT03781830T ATE410419T1 AT E410419 T1 ATE410419 T1 AT E410419T1 AT 03781830 T AT03781830 T AT 03781830T AT 03781830 T AT03781830 T AT 03781830T AT E410419 T1 ATE410419 T1 AT E410419T1
Authority
AT
Austria
Prior art keywords
thc
cannabinoid
esters
crystalline derivatives
purifying cannabinoids
Prior art date
Application number
AT03781830T
Other languages
German (de)
English (en)
Inventor
John Duchek
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Application granted granted Critical
Publication of ATE410419T1 publication Critical patent/ATE410419T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
AT03781830T 2002-11-12 2003-11-06 Cannabinoid kristalline derivate und verfahren zur reinigung von cannabinoiden ATE410419T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42554302P 2002-11-12 2002-11-12
US43502702P 2002-12-20 2002-12-20

Publications (1)

Publication Number Publication Date
ATE410419T1 true ATE410419T1 (de) 2008-10-15

Family

ID=32314593

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03781830T ATE410419T1 (de) 2002-11-12 2003-11-06 Cannabinoid kristalline derivate und verfahren zur reinigung von cannabinoiden

Country Status (13)

Country Link
US (1) US7402686B2 (enExample)
EP (1) EP1560819B1 (enExample)
JP (1) JP2006508132A (enExample)
AT (1) ATE410419T1 (enExample)
AU (1) AU2003287585B2 (enExample)
CA (1) CA2504743C (enExample)
DE (1) DE60324011D1 (enExample)
DK (1) DK1560819T3 (enExample)
ES (1) ES2315548T3 (enExample)
MX (1) MXPA05004966A (enExample)
PT (1) PT1560819E (enExample)
SI (1) SI1560819T1 (enExample)
WO (1) WO2004043946A1 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1428526A1 (en) * 2002-12-13 2004-06-16 Rijksuniversiteit Groningen Formulation for fast dissolution of lipophilic compounds
WO2006007734A1 (de) * 2004-07-19 2006-01-26 Cilag Ltd. Verfahren zur gewinnung von reinem tetrahydrocannabinol
EA200701246A1 (ru) * 2004-12-09 2008-06-30 Инсис Терапьютикс, Инк. Стабильные при комнатной температуре составы дронабинола
AU2012201041B2 (en) * 2005-09-29 2012-12-06 Albany Molecular Research, Inc. Process for production of delta-9-tetrahydrocannabinol
EP2578577A1 (en) * 2005-09-29 2013-04-10 Albany Molecular Research, Inc. Sulfonyl esters of tetrahydrocannabinol and derivatives thereof
CA2659775A1 (en) * 2006-08-04 2008-02-14 Insys Therapeutics Inc. Aqueous dronabinol formulations
GB0702895D0 (en) * 2007-02-14 2007-03-28 Resolution Chemicals Ltd Delta 9 tetrahydrocannabinol derivatives
GB0703284D0 (en) 2007-02-20 2007-03-28 Resolution Chemicals Ltd Delta 9 - tetrahydrocannabinol processing
CA2698752A1 (en) * 2007-08-06 2009-02-12 Insys Therapeutics Inc. Oral cannabinoid liquid formulations and methods of treatment
WO2009099868A1 (en) * 2008-02-06 2009-08-13 Mallinckrodt Inc. Process for the preparation of (-) -delta 9-tetrahydrocannabinol
US9220294B2 (en) 2014-02-11 2015-12-29 Timothy McCullough Methods and devices using cannabis vapors
US10821240B2 (en) 2014-02-11 2020-11-03 Vapor Cartridge Technology Llc Methods and drug delivery devices using cannabis
US9380813B2 (en) 2014-02-11 2016-07-05 Timothy McCullough Drug delivery system and method
US9539295B2 (en) 2014-12-05 2017-01-10 Bradley Michael Bohus Cannabidiol (CBD) enriched alcohol
US9585867B2 (en) 2015-08-06 2017-03-07 Charles Everett Ankner Cannabinod formulation for the sedation of a human or animal
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
US10272360B2 (en) 2017-08-05 2019-04-30 Priya Naturals, Inc. Phytochemical extraction system and methods to extract phytochemicals from plants including plants of the family Cannabaceae sensu stricto
EP3745884A1 (en) 2018-01-31 2020-12-09 Canopy Holdings, Llc Hemp powder
US10897925B2 (en) 2018-07-27 2021-01-26 Joseph Pandolfino Articles and formulations for smoking products and vaporizers
US20200035118A1 (en) 2018-07-27 2020-01-30 Joseph Pandolfino Methods and products to facilitate smokers switching to a tobacco heating product or e-cigarettes
US11040932B2 (en) 2018-10-10 2021-06-22 Treehouse Biotech, Inc. Synthesis of cannabigerol
GB201910389D0 (en) * 2019-07-19 2019-09-04 Gw Pharma Ltd Novel compounds, methods for their manufacture, and uses thereof
US11925907B2 (en) 2019-07-22 2024-03-12 Canopy Growth Corporation Continuous crystallization of cannabinoids in a stirred-tank reactor
WO2021055079A1 (en) 2019-09-16 2021-03-25 Vapor Cartridge Technology Llc Drug delivery system with stackable substrates
JP2023512578A (ja) * 2020-02-06 2023-03-27 ロンドン ファーマシューティカルズ アンド リサーチ コーポレーション Cアナビンオイド硫酸エステル、その塩及び用途
AU2022362107A1 (en) * 2021-10-11 2024-05-02 Anebulo Pharmaceuticals, Inc. Crystalline forms of a cannabinoid receptor type 1 (cb1) modulator and methods of use and preparation thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636058A (en) 1966-03-25 1972-01-18 Hoffmann La Roche 7 10 - dihydro - 3 - alkyl - 6h - dibenzo(b d) pyran-6 9(8h)-diones and 5-hydroxy-7-alkyl-4-chromanones
US3507888A (en) 1966-08-30 1970-04-21 Searle & Co Process and intermediates for manufacture of 17-oxygenated estr-4-en-3-ones
US3728360A (en) 1971-08-31 1973-04-17 Little Inc A Ester derivatives of tetrahydrocannabinol
US4188495A (en) 1977-11-14 1980-02-12 Pfizer Inc. 1,9-Dihydroxyoctahydrophenanthrenes and intermediates therefor
US4206225A (en) 1978-09-22 1980-06-03 Pfizer Inc. 2,10-Disubstituted dibenzo[b,d]pyrans and benzo[c]quinolines
US4341906A (en) 1979-09-24 1982-07-27 Pfizer Inc. 1,9-Dihydroxyoctahydrophenanthrenes
US4381399A (en) 1981-12-21 1983-04-26 Aerojet-General Corporation Purification of tetrahydrodibenzo[b,d]pyrans from crude synthetic mixtures
GB9303911D0 (en) 1993-02-26 1993-04-14 Zeneca Ltd Chemical process
JP3384163B2 (ja) * 1994-11-09 2003-03-10 株式会社ニコン 顕微鏡対物レンズ
US6008383A (en) 1998-10-26 1999-12-28 University Of Mississippi Method of preparing delta-9-tetrahydrocannabinol esters
WO2006000734A1 (en) 2004-06-23 2006-01-05 Bp P.L.C. The synthesis of the micro-porous silica gel and its application to the preparation of catalysts for c2 oxygenates synthesis from syngas

Also Published As

Publication number Publication date
AU2003287585A1 (en) 2004-06-03
EP1560819B1 (en) 2008-10-08
EP1560819A1 (en) 2005-08-10
PT1560819E (pt) 2008-11-03
WO2004043946A1 (en) 2004-05-27
ES2315548T3 (es) 2009-04-01
SI1560819T1 (sl) 2009-06-30
JP2006508132A (ja) 2006-03-09
US7402686B2 (en) 2008-07-22
DK1560819T3 (da) 2009-02-09
AU2003287585B2 (en) 2009-05-07
US20060094774A1 (en) 2006-05-04
CA2504743A1 (en) 2004-05-27
DE60324011D1 (de) 2008-11-20
CA2504743C (en) 2012-04-24
MXPA05004966A (es) 2005-08-02

Similar Documents

Publication Publication Date Title
ATE410419T1 (de) Cannabinoid kristalline derivate und verfahren zur reinigung von cannabinoiden
DE60330732D1 (de) Wahrscheinlichkeitsschätzung zur klassifikation mittels des K nächsten Nachbarn
DE60314865D1 (de) Verfahren zur herstellung von modifiziertem polymer, danach erhaltenes modifiziertes polymer und kautschukzusammensetzung
BRPI0518647A2 (pt) processo para a produÇço de um composto, e, composto
ATE291024T1 (de) Neue 4-aminofuropyrimidine und ihre verwendung
CY1109569T1 (el) Υποκατεστημενα παραγωγα κυκλοεξανο-1,4-διαμινης
DK1513800T3 (da) Benzoylureido-kanelsyrederivater, fremgangsmåde til deres anvendelse
ATE420167T1 (de) Reinigungsverfahren für plasmid-dna
DE50301594D1 (de) Verfahren zur Herstellung von Emulsionspolymeren mit hoher Reinheit
ATE354583T1 (de) Verfahren zur herstellung c-7 substituierter 5- androstene
ATE465998T1 (de) Verfahren zur herstellung und reinigung von 1,7'- dimethyl-2'-propyl-2,5'-bi-1h-benzimidazol
ECSP055844A (es) Nuevos compuestos triciclicos
DE60303904D1 (de) Verfahren zur Synthese von (2S)-Indolin-2-carbonsäure, und Verwendung in der Synthese von Perindopril
DE60310855D1 (de) Anlage und Verfahren zur Herstellung von Synthesegas
NO20044446L (no) Anvendelse av polymerer omfattende termoplastiske polymerer som filterhjelpemidler og/eller stabiliseringsmiddel
EE05428B1 (et) Protsess ülipuhta perindopriili ja sünteesi kasulike vaheühendite valmistamiseks
ATE397620T1 (de) Aufreinigungsverfahren, das eine mikrofiltration bei erhöhten temperaturen beinhaltet
EA200501900A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
BRPI0507886A (pt) método de purificação de albumina compreendendo uma etapa de nanofiltração, solução e composição para uso terapêutico contendo-o
DE502005008252D1 (de) Verfahren zur herstellung von harnstoff aus erdgas
ATE411301T1 (de) Diphenylurea-derivative und ihre verwendung als chloridkanalblocker
MY142634A (en) Method for synthesis of (2s,3as,7as)-perhydroindole-2-carboxylic acid and esters thereof, and use in the synthesis of perindopril
ATE269858T1 (de) Kristallines oder kristallisiertes säureadditionssalz von losartan und verfahren zur reinigung von losartan
DE602004004215D1 (de) Verfahren zur Herstellung von hochreinen, niedrigmolekularen Heparinen
IS7477A (is) Aðferð við framleiðslu sýrusalts af gemifloxasíni

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1560819

Country of ref document: EP

REN Ceased due to non-payment of the annual fee